Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Encompass Health Corporation

Goldman Sachs analyst David Roman maintained a Buy rating on GE Healthcare Technologies Inc today and set a price target of $81.00. According to Ti...

GE Healthcare Technologies Inc (GEHC) Receives a Buy from Goldman Sachs

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Encompass Health (EHC) and Lifestance Health Group (...

Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC) and Lifestance Health Group (LFST)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ascendis Pharma (ASND), Encompass Health (EHC) and L...

Analysts Are Bullish on Top Healthcare Stocks: Ascendis Pharma (ASND), Encompass Health (EHC)

IEH received a Buy rating and a $26.00 price target from Atrium Research analyst today. Currently, the analyst consensus on IEH is a Moderate Buy w...

IEH (IEHC) Gets a Buy from Atrium Research

Markets React to Oil, Risk, and Rotation U.S. stocks moved lower last week as war risk and rising oil prices weighed on sentiment. The S&P 500 (SPX...

The Week That Was, The Week Ahead: Macro and Markets, Mar. 29

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ionis Pharmaceuticals (IONS), GE Healthcare Technologies Inc (GEH...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS), GE Healthcare Technologies Inc (GEHC) and Insmed (INSM)

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on GE Healthcare Technologies Inc today and set a price target of $98.00. According to Ti...

Stifel Nicolaus Remains a Buy on GE Healthcare Technologies Inc (GEHC)

An announcement from Sweet Earth Holdings ( ($TSE:SE) ) is now available. Sweet Earth Holdings has amended its business combination agreement with ...

Sweet Earth Extends Vesalius Deal Deadline and Secures Additional SPV Financing

Analysts fell to the sidelines weighing in on GE Healthcare Technologies Inc (GEHC – Research Report) and Vertex Pharmaceuticals (VRTX – Research R...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EHC	$107.23	+1.48%	712.28K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EHC	$107.23	+1.5%	712.28K
3
4
5
6

EHC

EHC

Get Encompass Health Corporation Data in Excel

Get Encompass Health Corporation Data in Excel